iCAD, Inc. (ICAD)
NASDAQ: ICAD · Real-Time Price · USD
1.830
+0.060 (3.39%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States.
It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.
The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
iCAD, Inc.
| Country | United States |
| Founded | 1984 |
| IPO Date | Dec 3, 1986 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 69 |
| CEO | Dana Brown |
Contact Details
Address: 98 Spit Brook Road, Suite 100 Nashua, New Hampshire 03062 United States | |
| Phone | 603 882 5200 |
| Website | icadmed.com |
Stock Details
| Ticker Symbol | ICAD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000749660 |
| CUSIP Number | 44934S206 |
| ISIN Number | US44934S2068 |
| Employer ID | 02-0377419 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dana R. Brown | President, Chief Executive Officer and Executive Chair |
| Eric Lonnqvist | Chief Financial Officer |
| Jonathan Go | Chief Technology Officer |
| Michelle Strong | Chief Operations Officer |
| Annette L. Heroux | Vice President of Administration |
| Brian Testa | Chief People Officer |
| Bill Keyes | Senior Vice President of Global Sales Operations |
| Vasu Avadhanula | Chief Product Officer |
| Peter Graham | Senior Vice President of North American Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | 8-K | Current Report |
| Aug 14, 2024 | 10-Q/A | [Amend] Quarterly report |
| Aug 14, 2024 | 10-Q | Quarterly Report |
| Aug 13, 2024 | 8-K | Current Report |
| Jul 2, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 14, 2024 | 8-K | Current Report |
| May 15, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |
| Apr 29, 2024 | DEF 14A | Other definitive proxy statements |